# Breastfeeding in Infancy and Adult Health: A Narrative Review

**Authors:** Eleftherios Panteris, Ioanna Kakatsaki, Ourania Galani, Zoi Koukou, Eleftheria Hatzidaki

PMC · DOI: 10.3390/children13020286 · 2026-02-19

## TL;DR

Breastfeeding in infancy is linked to small long-term health benefits in adulthood, such as lower risk of heart disease and diabetes, but these effects are modest compared to other lifestyle factors.

## Contribution

The paper provides a narrative review showing that breastfeeding has small but consistent associations with better adult cardiometabolic and neurobehavioral outcomes.

## Key findings

- Breastfeeding is associated with modest reductions in adult cardiometabolic risk factors like adiposity and type 2 diabetes.
- Genetic studies suggest a protective association with coronary outcomes, but limited mediation via lipid pathways.
- Breastfeeding is linked to small improvements in cognitive performance and educational attainment.

## Abstract

What are the main findings?
Breastfeeding in infancy is consistently associated with small favourable shifts in adult cardiometabolic risk (adiposity, metabolic syndrome, type 2 diabetes) across large cohorts.Genetic epidemiology (including Mendelian randomisation) generally supports a modest protective association with coronary outcomes, but suggests limited mediation via lipids and substantial confounding in observational estimates.

Breastfeeding in infancy is consistently associated with small favourable shifts in adult cardiometabolic risk (adiposity, metabolic syndrome, type 2 diabetes) across large cohorts.

Genetic epidemiology (including Mendelian randomisation) generally supports a modest protective association with coronary outcomes, but suggests limited mediation via lipids and substantial confounding in observational estimates.

What are the implications of the main findings?
Breastfeeding should be promoted as a population-level prevention strategy with modest long-term benefits, while recognising that later-life behavioural and clinical risk factors dominate individual adult risk.Future studies should strengthen causal inference using triangulation (prospective cohorts, sibling/twin designs, and genetic approaches) and improve exposure ascertainment (duration, exclusivity, and neonatal intensive care feeding pathways).

Breastfeeding should be promoted as a population-level prevention strategy with modest long-term benefits, while recognising that later-life behavioural and clinical risk factors dominate individual adult risk.

Future studies should strengthen causal inference using triangulation (prospective cohorts, sibling/twin designs, and genetic approaches) and improve exposure ascertainment (duration, exclusivity, and neonatal intensive care feeding pathways).

Within the Developmental Origins of Health and Disease (DOHaD) framework, breast-feeding is a modifiable early postnatal exposure, but its long-term associations are difficult to separate from socioeconomic and family context. We conducted a structured literature search (PubMed/MEDLINE and Scopus; January 2015–December 2025) and prioritised large prospective/birth cohorts and genetic epidemiology studies reporting quantitative associations between breastfeeding in infancy (ever versus never, duration and, where available, exclusivity) and adult outcomes. Eighteen key primary studies were included in evidence tables across cardiometabolic, cancer, and neurocognitive domains. Overall, breastfeeding was associated with modestly lower all-cause and cardiovascular mortality, small reductions in cardiovascular disease and type 2 diabetes, and slightly more favour-able cardiometabolic profiles, including lower adiposity and higher HDL cholesterol. Where reported, effect sizes were generally small (e.g., hazard ratios typically close to 1.00), indicating limited clinical impact at the individual level but potential population relevance. Genetic analyses provide cautious support for a protective association with coronary outcomes, although lipid-mediated pathways appear to explain only a small proportion of the observed associations. Evidence for adult cancer outcomes remains mixed and largely inconclusive, while longer breastfeeding is associated with small ad-vantages in cognitive performance, educational attainment and selected psychological outcomes. Taken together, current evidence suggests that breastfeeding is associated with modestly more favourable adult cardiometabolic and neurobehavioural profiles, but its contribution to long-term health is small relative to the influence of later-life lifestyle and clinical risk factors and should therefore be interpreted cautiously.

## Linked entities

- **Diseases:** type 2 diabetes (MONDO:0005148), metabolic syndrome (MONDO:0000816), cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}
- **Diseases:** asthma (MESH:D001249), anxiety (MESH:D001007), Mental Conditions (MESH:D001523), Diabetes (MESH:D003920), Cancer (MESH:D009369), pain (MESH:D010146), physical (MESH:D059445), chronic respiratory diseases (MESH:D012140), coronary heart disease (MESH:D003327), injury to (MESH:D014947), disease (MESH:D004194), respiratory infections (MESH:D012141), chronic systemic inflammation (MESH:D007249), Metabolic Syndrome (MESH:D024821), anxiety disorders (MESH:D001008), major depression (MESH:D003865), metabolic disorders (MESH:D008659), colorectal adenomas (MESH:D000236), stroke (MESH:D020521), overweight (MESH:D050177), oesophageal carcinogenesis (MESH:D063646), NCDs (MESH:D000073296), benign colorectal polyps (MESH:D003111), obesity (MESH:D009765), food allergy (MESH:D005512), DOHaD (OMIM:603663), myocardial infarction (MESH:D009203), preterm birth (MESH:D047928), Cardiovascular diseases (MESH:D002318), gastrointestinal infections (MESH:D005767), sudden infant death syndrome (MESH:D013398), hypertension (MESH:D006973), venous thromboembolism (MESH:D054556), deaths (MESH:D003643), breast and ovarian cancer (MESH:D061325), Colorectal cancer (MESH:D015179), atrial fibrillation/flutter (MESH:D001282), appendicitis (MESH:D001064), breast and endometrial cancer (MESH:C537243), chronic (MESH:D002908), cardiovascular and respiratory deaths (MESH:D018376), Coronary (MESH:D003323), atopic dermatitis (MESH:D003876), lipid (MESH:D011017), prematurity (MESH:C536271), coronary atherosclerosis (MESH:D003324), type 1 diabetes (MESH:D003922), lung, endometrial, pancreatic or non-Hodgkin lymphoma (MESH:D008228), ovarian cancer (MESH:D010051), allergy (MESH:D004342), type 2 diabetes (MESH:D003924), social anxiety disorder (MESH:D000072861), heart failure (MESH:D006333), depressive symptom (MESH:D003866), breast cancer (MESH:D001943), adiposity (MESH:D018205)
- **Chemicals:** triglyceride (MESH:D014280), choline (MESH:D002794), cholesterol (MESH:D002784), polyunsaturated fatty acids (MESH:D005231), arachidonic acids (MESH:D001095), docosahexaenoic (-), melatonin (MESH:D008550), glucose (MESH:D005947), short-chain fatty acid (MESH:D005232), alcohol (MESH:D000438), lipid (MESH:D008055)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Bifidobacterium (genus) [taxon 1678], Homo sapiens (human, species) [taxon 9606], Bacteroides (genus) [taxon 816], gut metagenome (species) [taxon 749906]

---
Source: https://tomesphere.com/paper/PMC12939404